Related Experiment Video
Updated: Jun 24, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Model Programs Addressing Perinatal Drug Exposure and Human Immunodeficiency Virus Infection: Integrating Women's and
Integrated programs addressing perinatal drug exposure and HIV infection can overcome challenges by coordinating funding, collaborating with agencies, and advocating for clients. These approaches support services for both women and children together.
Area of Science:
- Perinatal health
- Public health policy
- Integrated healthcare services
Background:
- Traditional approaches often create a conflict between maternal and infant interests regarding perinatal drug exposure and HIV.
- Existing health services may not adequately address the complex needs of women and children affected by these issues concurrently.
Purpose of the Study:
- To highlight programs integrating women's and children's services for perinatal drug exposure and HIV.
- To identify challenges faced by these integrated programs.
- To present strategies and policy recommendations for overcoming these barriers.
Main Methods:
- Review of integrated service programs.
- Analysis of challenges including funding, institutional, professional, regulatory, and political issues.
- Identification of successful strategies and policy recommendations.
Main Results:
- Integrated programs demonstrate success in addressing co-occurring perinatal drug exposure and HIV.
- Key challenges include funding limitations, institutional barriers, professional attitudes, regulatory constraints, and local politics.
- Effective strategies involve creative funding coordination, partnerships with child protective agencies, inter-agency collaboration, and client advocacy.
Conclusions:
- Integrated service models are crucial for effectively serving women and children affected by perinatal drug exposure and HIV.
- Overcoming identified barriers requires innovative strategies and policy changes.
- Policy shifts supporting co-located or integrated services can foster better outcomes for this population.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Intrauterine Drug Delivery Systems
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results from...
Teratogenicity

